COVID-19 Impact on Global Drug-Coated Balloons Market Insights, Forecast to 2026
Drug-Coated Balloons market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug-Coated Balloons market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Drug-Coated Balloons market is segmented into
The Drug-Coated Balloons market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drug-Coated Balloons market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Drug-Coated Balloons Market Share Analysis
Drug-Coated Balloons market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Drug-Coated Balloons by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Drug-Coated Balloons business, the date to enter into the Drug-Coated Balloons market, Drug-Coated Balloons product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Drug-Coated Balloons market is segmented into
- DCB for Peripheral Artery Disease
- DCB for Coronary Artery Disease
- DCB for Other Indications
- Hospitals
- Cardiac Catheterization Labs
- ASCs
The Drug-Coated Balloons market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drug-Coated Balloons market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Drug-Coated Balloons Market Share Analysis
Drug-Coated Balloons market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Drug-Coated Balloons by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Drug-Coated Balloons business, the date to enter into the Drug-Coated Balloons market, Drug-Coated Balloons product introduction, recent developments, etc.
The major vendors covered:
- Medtronic
- BD
- B. Braun Melsungen
- Koninklijke Philips
- Boston Scientific
- Opto Circuits (India)
- Acotec Scientific
- AR Baltic Medical
- Acrostak
- Biosensors International Group
- BioMed
- Concept Medical
- Cardionovum
- Endocor
- Hexacath Sverige
- iVascular SLU
- Minvasys
- MedAlliance
- QT Vascular
- RD Global-Invamed
- SurModics
- Terumo
1 STUDY COVERAGE
1.1 Drug-Coated Balloons Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Drug-Coated Balloons Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Drug-Coated Balloons Market Size Growth Rate by Type
1.4.2 DCB for Peripheral Artery Disease
1.4.3 DCB for Coronary Artery Disease
1.4.4 DCB for Other Indications
1.5 Market by Application
1.5.1 Global Drug-Coated Balloons Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Cardiac Catheterization Labs
1.5.4 ASCs
1.6 Coronavirus Disease 2019 (Covid-19): Drug-Coated Balloons Industry Impact
1.6.1 How the Covid-19 is Affecting the Drug-Coated Balloons Industry
1.6.1.1 Drug-Coated Balloons Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Drug-Coated Balloons Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Drug-Coated Balloons Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Drug-Coated Balloons Market Size Estimates and Forecasts
2.1.1 Global Drug-Coated Balloons Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Drug-Coated Balloons Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Drug-Coated Balloons Production Estimates and Forecasts 2015-2026
2.2 Global Drug-Coated Balloons Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Drug-Coated Balloons Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Drug-Coated Balloons Manufacturers Geographical Distribution
2.4 Key Trends for Drug-Coated Balloons Markets & Products
2.5 Primary Interviews with Key Drug-Coated Balloons Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Drug-Coated Balloons Manufacturers by Production Capacity
3.1.1 Global Top Drug-Coated Balloons Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Drug-Coated Balloons Manufacturers by Production (2015-2020)
3.1.3 Global Top Drug-Coated Balloons Manufacturers Market Share by Production
3.2 Global Top Drug-Coated Balloons Manufacturers by Revenue
3.2.1 Global Top Drug-Coated Balloons Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Drug-Coated Balloons Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Drug-Coated Balloons Revenue in 2019
3.3 Global Drug-Coated Balloons Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 DRUG-COATED BALLOONS PRODUCTION BY REGIONS
4.1 Global Drug-Coated Balloons Historic Market Facts & Figures by Regions
4.1.1 Global Top Drug-Coated Balloons Regions by Production (2015-2020)
4.1.2 Global Top Drug-Coated Balloons Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Drug-Coated Balloons Production (2015-2020)
4.2.2 North America Drug-Coated Balloons Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Drug-Coated Balloons Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Drug-Coated Balloons Production (2015-2020)
4.3.2 Europe Drug-Coated Balloons Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Drug-Coated Balloons Import & Export (2015-2020)
4.4 China
4.4.1 China Drug-Coated Balloons Production (2015-2020)
4.4.2 China Drug-Coated Balloons Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Drug-Coated Balloons Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Drug-Coated Balloons Production (2015-2020)
4.5.2 Japan Drug-Coated Balloons Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Drug-Coated Balloons Import & Export (2015-2020)
5 DRUG-COATED BALLOONS CONSUMPTION BY REGION
5.1 Global Top Drug-Coated Balloons Regions by Consumption
5.1.1 Global Top Drug-Coated Balloons Regions by Consumption (2015-2020)
5.1.2 Global Top Drug-Coated Balloons Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Drug-Coated Balloons Consumption by Application
5.2.2 North America Drug-Coated Balloons Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Drug-Coated Balloons Consumption by Application
5.3.2 Europe Drug-Coated Balloons Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Drug-Coated Balloons Consumption by Application
5.4.2 Asia Pacific Drug-Coated Balloons Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Drug-Coated Balloons Consumption by Application
5.5.2 Central & South America Drug-Coated Balloons Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Drug-Coated Balloons Consumption by Application
5.6.2 Middle East and Africa Drug-Coated Balloons Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Drug-Coated Balloons Market Size by Type (2015-2020)
6.1.1 Global Drug-Coated Balloons Production by Type (2015-2020)
6.1.2 Global Drug-Coated Balloons Revenue by Type (2015-2020)
6.1.3 Drug-Coated Balloons Price by Type (2015-2020)
6.2 Global Drug-Coated Balloons Market Forecast by Type (2021-2026)
6.2.1 Global Drug-Coated Balloons Production Forecast by Type (2021-2026)
6.2.2 Global Drug-Coated Balloons Revenue Forecast by Type (2021-2026)
6.2.3 Global Drug-Coated Balloons Price Forecast by Type (2021-2026)
6.3 Global Drug-Coated Balloons Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Drug-Coated Balloons Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Drug-Coated Balloons Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Medtronic
8.1.1 Medtronic Corporation Information
8.1.2 Medtronic Overview and Its Total Revenue
8.1.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Medtronic Product Description
8.1.5 Medtronic Recent Development
8.2 BD
8.2.1 BD Corporation Information
8.2.2 BD Overview and Its Total Revenue
8.2.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 BD Product Description
8.2.5 BD Recent Development
8.3 B. Braun Melsungen
8.3.1 B. Braun Melsungen Corporation Information
8.3.2 B. Braun Melsungen Overview and Its Total Revenue
8.3.3 B. Braun Melsungen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 B. Braun Melsungen Product Description
8.3.5 B. Braun Melsungen Recent Development
8.4 Koninklijke Philips
8.4.1 Koninklijke Philips Corporation Information
8.4.2 Koninklijke Philips Overview and Its Total Revenue
8.4.3 Koninklijke Philips Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Koninklijke Philips Product Description
8.4.5 Koninklijke Philips Recent Development
8.5 Boston Scientific
8.5.1 Boston Scientific Corporation Information
8.5.2 Boston Scientific Overview and Its Total Revenue
8.5.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Boston Scientific Product Description
8.5.5 Boston Scientific Recent Development
8.6 Opto Circuits (India)
8.6.1 Opto Circuits (India) Corporation Information
8.6.2 Opto Circuits (India) Overview and Its Total Revenue
8.6.3 Opto Circuits (India) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Opto Circuits (India) Product Description
8.6.5 Opto Circuits (India) Recent Development
8.7 Acotec Scientific
8.7.1 Acotec Scientific Corporation Information
8.7.2 Acotec Scientific Overview and Its Total Revenue
8.7.3 Acotec Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Acotec Scientific Product Description
8.7.5 Acotec Scientific Recent Development
8.8 AR Baltic Medical
8.8.1 AR Baltic Medical Corporation Information
8.8.2 AR Baltic Medical Overview and Its Total Revenue
8.8.3 AR Baltic Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 AR Baltic Medical Product Description
8.8.5 AR Baltic Medical Recent Development
8.9 Acrostak
8.9.1 Acrostak Corporation Information
8.9.2 Acrostak Overview and Its Total Revenue
8.9.3 Acrostak Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Acrostak Product Description
8.9.5 Acrostak Recent Development
8.10 Biosensors International Group
8.10.1 Biosensors International Group Corporation Information
8.10.2 Biosensors International Group Overview and Its Total Revenue
8.10.3 Biosensors International Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Biosensors International Group Product Description
8.10.5 Biosensors International Group Recent Development
8.11 BioMed
8.11.1 BioMed Corporation Information
8.11.2 BioMed Overview and Its Total Revenue
8.11.3 BioMed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 BioMed Product Description
8.11.5 BioMed Recent Development
8.12 Concept Medical
8.12.1 Concept Medical Corporation Information
8.12.2 Concept Medical Overview and Its Total Revenue
8.12.3 Concept Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Concept Medical Product Description
8.12.5 Concept Medical Recent Development
8.13 Cardionovum
8.13.1 Cardionovum Corporation Information
8.13.2 Cardionovum Overview and Its Total Revenue
8.13.3 Cardionovum Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Cardionovum Product Description
8.13.5 Cardionovum Recent Development
8.14 Endocor
8.14.1 Endocor Corporation Information
8.14.2 Endocor Overview and Its Total Revenue
8.14.3 Endocor Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Endocor Product Description
8.14.5 Endocor Recent Development
8.15 Hexacath Sverige
8.15.1 Hexacath Sverige Corporation Information
8.15.2 Hexacath Sverige Overview and Its Total Revenue
8.15.3 Hexacath Sverige Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Hexacath Sverige Product Description
8.15.5 Hexacath Sverige Recent Development
8.16 iVascular SLU
8.16.1 iVascular SLU Corporation Information
8.16.2 iVascular SLU Overview and Its Total Revenue
8.16.3 iVascular SLU Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.16.4 iVascular SLU Product Description
8.16.5 iVascular SLU Recent Development
8.17 Minvasys
8.17.1 Minvasys Corporation Information
8.17.2 Minvasys Overview and Its Total Revenue
8.17.3 Minvasys Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.17.4 Minvasys Product Description
8.17.5 Minvasys Recent Development
8.18 MedAlliance
8.18.1 MedAlliance Corporation Information
8.18.2 MedAlliance Overview and Its Total Revenue
8.18.3 MedAlliance Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.18.4 MedAlliance Product Description
8.18.5 MedAlliance Recent Development
8.19 QT Vascular
8.19.1 QT Vascular Corporation Information
8.19.2 QT Vascular Overview and Its Total Revenue
8.19.3 QT Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.19.4 QT Vascular Product Description
8.19.5 QT Vascular Recent Development
8.20 RD Global-Invamed
8.20.1 RD Global-Invamed Corporation Information
8.20.2 RD Global-Invamed Overview and Its Total Revenue
8.20.3 RD Global-Invamed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.20.4 RD Global-Invamed Product Description
8.20.5 RD Global-Invamed Recent Development
8.21 SurModics
8.21.1 SurModics Corporation Information
8.21.2 SurModics Overview and Its Total Revenue
8.21.3 SurModics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.21.4 SurModics Product Description
8.21.5 SurModics Recent Development
8.22 Terumo
8.22.1 Terumo Corporation Information
8.22.2 Terumo Overview and Its Total Revenue
8.22.3 Terumo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.22.4 Terumo Product Description
8.22.5 Terumo Recent Development
8.23 Wellinq
8.23.1 Wellinq Corporation Information
8.23.2 Wellinq Overview and Its Total Revenue
8.23.3 Wellinq Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.23.4 Wellinq Product Description
8.23.5 Wellinq Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Drug-Coated Balloons Regions Forecast by Revenue (2021-2026)
9.2 Global Top Drug-Coated Balloons Regions Forecast by Production (2021-2026)
9.3 Key Drug-Coated Balloons Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 DRUG-COATED BALLOONS CONSUMPTION FORECAST BY REGION
10.1 Global Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
10.2 North America Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
10.3 Europe Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
10.5 Latin America Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Drug-Coated Balloons Sales Channels
11.2.2 Drug-Coated Balloons Distributors
11.3 Drug-Coated Balloons Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL DRUG-COATED BALLOONS STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Drug-Coated Balloons Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Drug-Coated Balloons Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Drug-Coated Balloons Market Size Growth Rate by Type
1.4.2 DCB for Peripheral Artery Disease
1.4.3 DCB for Coronary Artery Disease
1.4.4 DCB for Other Indications
1.5 Market by Application
1.5.1 Global Drug-Coated Balloons Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Cardiac Catheterization Labs
1.5.4 ASCs
1.6 Coronavirus Disease 2019 (Covid-19): Drug-Coated Balloons Industry Impact
1.6.1 How the Covid-19 is Affecting the Drug-Coated Balloons Industry
1.6.1.1 Drug-Coated Balloons Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Drug-Coated Balloons Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Drug-Coated Balloons Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Drug-Coated Balloons Market Size Estimates and Forecasts
2.1.1 Global Drug-Coated Balloons Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Drug-Coated Balloons Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Drug-Coated Balloons Production Estimates and Forecasts 2015-2026
2.2 Global Drug-Coated Balloons Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Drug-Coated Balloons Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Drug-Coated Balloons Manufacturers Geographical Distribution
2.4 Key Trends for Drug-Coated Balloons Markets & Products
2.5 Primary Interviews with Key Drug-Coated Balloons Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Drug-Coated Balloons Manufacturers by Production Capacity
3.1.1 Global Top Drug-Coated Balloons Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Drug-Coated Balloons Manufacturers by Production (2015-2020)
3.1.3 Global Top Drug-Coated Balloons Manufacturers Market Share by Production
3.2 Global Top Drug-Coated Balloons Manufacturers by Revenue
3.2.1 Global Top Drug-Coated Balloons Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Drug-Coated Balloons Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Drug-Coated Balloons Revenue in 2019
3.3 Global Drug-Coated Balloons Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 DRUG-COATED BALLOONS PRODUCTION BY REGIONS
4.1 Global Drug-Coated Balloons Historic Market Facts & Figures by Regions
4.1.1 Global Top Drug-Coated Balloons Regions by Production (2015-2020)
4.1.2 Global Top Drug-Coated Balloons Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Drug-Coated Balloons Production (2015-2020)
4.2.2 North America Drug-Coated Balloons Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Drug-Coated Balloons Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Drug-Coated Balloons Production (2015-2020)
4.3.2 Europe Drug-Coated Balloons Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Drug-Coated Balloons Import & Export (2015-2020)
4.4 China
4.4.1 China Drug-Coated Balloons Production (2015-2020)
4.4.2 China Drug-Coated Balloons Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Drug-Coated Balloons Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Drug-Coated Balloons Production (2015-2020)
4.5.2 Japan Drug-Coated Balloons Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Drug-Coated Balloons Import & Export (2015-2020)
5 DRUG-COATED BALLOONS CONSUMPTION BY REGION
5.1 Global Top Drug-Coated Balloons Regions by Consumption
5.1.1 Global Top Drug-Coated Balloons Regions by Consumption (2015-2020)
5.1.2 Global Top Drug-Coated Balloons Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Drug-Coated Balloons Consumption by Application
5.2.2 North America Drug-Coated Balloons Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Drug-Coated Balloons Consumption by Application
5.3.2 Europe Drug-Coated Balloons Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Drug-Coated Balloons Consumption by Application
5.4.2 Asia Pacific Drug-Coated Balloons Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Drug-Coated Balloons Consumption by Application
5.5.2 Central & South America Drug-Coated Balloons Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Drug-Coated Balloons Consumption by Application
5.6.2 Middle East and Africa Drug-Coated Balloons Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Drug-Coated Balloons Market Size by Type (2015-2020)
6.1.1 Global Drug-Coated Balloons Production by Type (2015-2020)
6.1.2 Global Drug-Coated Balloons Revenue by Type (2015-2020)
6.1.3 Drug-Coated Balloons Price by Type (2015-2020)
6.2 Global Drug-Coated Balloons Market Forecast by Type (2021-2026)
6.2.1 Global Drug-Coated Balloons Production Forecast by Type (2021-2026)
6.2.2 Global Drug-Coated Balloons Revenue Forecast by Type (2021-2026)
6.2.3 Global Drug-Coated Balloons Price Forecast by Type (2021-2026)
6.3 Global Drug-Coated Balloons Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Drug-Coated Balloons Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Drug-Coated Balloons Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Medtronic
8.1.1 Medtronic Corporation Information
8.1.2 Medtronic Overview and Its Total Revenue
8.1.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Medtronic Product Description
8.1.5 Medtronic Recent Development
8.2 BD
8.2.1 BD Corporation Information
8.2.2 BD Overview and Its Total Revenue
8.2.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 BD Product Description
8.2.5 BD Recent Development
8.3 B. Braun Melsungen
8.3.1 B. Braun Melsungen Corporation Information
8.3.2 B. Braun Melsungen Overview and Its Total Revenue
8.3.3 B. Braun Melsungen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 B. Braun Melsungen Product Description
8.3.5 B. Braun Melsungen Recent Development
8.4 Koninklijke Philips
8.4.1 Koninklijke Philips Corporation Information
8.4.2 Koninklijke Philips Overview and Its Total Revenue
8.4.3 Koninklijke Philips Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Koninklijke Philips Product Description
8.4.5 Koninklijke Philips Recent Development
8.5 Boston Scientific
8.5.1 Boston Scientific Corporation Information
8.5.2 Boston Scientific Overview and Its Total Revenue
8.5.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Boston Scientific Product Description
8.5.5 Boston Scientific Recent Development
8.6 Opto Circuits (India)
8.6.1 Opto Circuits (India) Corporation Information
8.6.2 Opto Circuits (India) Overview and Its Total Revenue
8.6.3 Opto Circuits (India) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Opto Circuits (India) Product Description
8.6.5 Opto Circuits (India) Recent Development
8.7 Acotec Scientific
8.7.1 Acotec Scientific Corporation Information
8.7.2 Acotec Scientific Overview and Its Total Revenue
8.7.3 Acotec Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Acotec Scientific Product Description
8.7.5 Acotec Scientific Recent Development
8.8 AR Baltic Medical
8.8.1 AR Baltic Medical Corporation Information
8.8.2 AR Baltic Medical Overview and Its Total Revenue
8.8.3 AR Baltic Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 AR Baltic Medical Product Description
8.8.5 AR Baltic Medical Recent Development
8.9 Acrostak
8.9.1 Acrostak Corporation Information
8.9.2 Acrostak Overview and Its Total Revenue
8.9.3 Acrostak Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Acrostak Product Description
8.9.5 Acrostak Recent Development
8.10 Biosensors International Group
8.10.1 Biosensors International Group Corporation Information
8.10.2 Biosensors International Group Overview and Its Total Revenue
8.10.3 Biosensors International Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Biosensors International Group Product Description
8.10.5 Biosensors International Group Recent Development
8.11 BioMed
8.11.1 BioMed Corporation Information
8.11.2 BioMed Overview and Its Total Revenue
8.11.3 BioMed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 BioMed Product Description
8.11.5 BioMed Recent Development
8.12 Concept Medical
8.12.1 Concept Medical Corporation Information
8.12.2 Concept Medical Overview and Its Total Revenue
8.12.3 Concept Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Concept Medical Product Description
8.12.5 Concept Medical Recent Development
8.13 Cardionovum
8.13.1 Cardionovum Corporation Information
8.13.2 Cardionovum Overview and Its Total Revenue
8.13.3 Cardionovum Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Cardionovum Product Description
8.13.5 Cardionovum Recent Development
8.14 Endocor
8.14.1 Endocor Corporation Information
8.14.2 Endocor Overview and Its Total Revenue
8.14.3 Endocor Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Endocor Product Description
8.14.5 Endocor Recent Development
8.15 Hexacath Sverige
8.15.1 Hexacath Sverige Corporation Information
8.15.2 Hexacath Sverige Overview and Its Total Revenue
8.15.3 Hexacath Sverige Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Hexacath Sverige Product Description
8.15.5 Hexacath Sverige Recent Development
8.16 iVascular SLU
8.16.1 iVascular SLU Corporation Information
8.16.2 iVascular SLU Overview and Its Total Revenue
8.16.3 iVascular SLU Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.16.4 iVascular SLU Product Description
8.16.5 iVascular SLU Recent Development
8.17 Minvasys
8.17.1 Minvasys Corporation Information
8.17.2 Minvasys Overview and Its Total Revenue
8.17.3 Minvasys Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.17.4 Minvasys Product Description
8.17.5 Minvasys Recent Development
8.18 MedAlliance
8.18.1 MedAlliance Corporation Information
8.18.2 MedAlliance Overview and Its Total Revenue
8.18.3 MedAlliance Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.18.4 MedAlliance Product Description
8.18.5 MedAlliance Recent Development
8.19 QT Vascular
8.19.1 QT Vascular Corporation Information
8.19.2 QT Vascular Overview and Its Total Revenue
8.19.3 QT Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.19.4 QT Vascular Product Description
8.19.5 QT Vascular Recent Development
8.20 RD Global-Invamed
8.20.1 RD Global-Invamed Corporation Information
8.20.2 RD Global-Invamed Overview and Its Total Revenue
8.20.3 RD Global-Invamed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.20.4 RD Global-Invamed Product Description
8.20.5 RD Global-Invamed Recent Development
8.21 SurModics
8.21.1 SurModics Corporation Information
8.21.2 SurModics Overview and Its Total Revenue
8.21.3 SurModics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.21.4 SurModics Product Description
8.21.5 SurModics Recent Development
8.22 Terumo
8.22.1 Terumo Corporation Information
8.22.2 Terumo Overview and Its Total Revenue
8.22.3 Terumo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.22.4 Terumo Product Description
8.22.5 Terumo Recent Development
8.23 Wellinq
8.23.1 Wellinq Corporation Information
8.23.2 Wellinq Overview and Its Total Revenue
8.23.3 Wellinq Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.23.4 Wellinq Product Description
8.23.5 Wellinq Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Drug-Coated Balloons Regions Forecast by Revenue (2021-2026)
9.2 Global Top Drug-Coated Balloons Regions Forecast by Production (2021-2026)
9.3 Key Drug-Coated Balloons Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 DRUG-COATED BALLOONS CONSUMPTION FORECAST BY REGION
10.1 Global Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
10.2 North America Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
10.3 Europe Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
10.5 Latin America Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Drug-Coated Balloons Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Drug-Coated Balloons Sales Channels
11.2.2 Drug-Coated Balloons Distributors
11.3 Drug-Coated Balloons Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL DRUG-COATED BALLOONS STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Drug-Coated Balloons Key Market Segments in This Study
Table 2. Ranking of Global Top Drug-Coated Balloons Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Drug-Coated Balloons Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of DCB for Peripheral Artery Disease
Table 5. Major Manufacturers of DCB for Coronary Artery Disease
Table 6. Major Manufacturers of DCB for Other Indications
Table 7. COVID-19 Impact Global Market: (Four Drug-Coated Balloons Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Drug-Coated Balloons Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Drug-Coated Balloons Players to Combat Covid-19 Impact
Table 12. Global Drug-Coated Balloons Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Drug-Coated Balloons Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Drug-Coated Balloons by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug-Coated Balloons as of 2019)
Table 16. Drug-Coated Balloons Manufacturing Base Distribution and Headquarters
Table 17. Manufacturers Drug-Coated Balloons Product Offered
Table 18. Date of Manufacturers Enter into Drug-Coated Balloons Market
Table 19. Key Trends for Drug-Coated Balloons Markets & Products
Table 20. Main Points Interviewed from Key Drug-Coated Balloons Players
Table 21. Global Drug-Coated Balloons Production Capacity by Manufacturers (2015-2020) (K Units)
Table 22. Global Drug-Coated Balloons Production Share by Manufacturers (2015-2020)
Table 23. Drug-Coated Balloons Revenue by Manufacturers (2015-2020) (Million US$)
Table 24. Drug-Coated Balloons Revenue Share by Manufacturers (2015-2020)
Table 25. Drug-Coated Balloons Price by Manufacturers 2015-2020 (USD/Unit)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Drug-Coated Balloons Production by Regions (2015-2020) (K Units)
Table 28. Global Drug-Coated Balloons Production Market Share by Regions (2015-2020)
Table 29. Global Drug-Coated Balloons Revenue by Regions (2015-2020) (US$ Million)
Table 30. Global Drug-Coated Balloons Revenue Market Share by Regions (2015-2020)
Table 31. Key Drug-Coated Balloons Players in North America
Table 32. Import & Export of Drug-Coated Balloons in North America (K Units)
Table 33. Key Drug-Coated Balloons Players in Europe
Table 34. Import & Export of Drug-Coated Balloons in Europe (K Units)
Table 35. Key Drug-Coated Balloons Players in China
Table 36. Import & Export of Drug-Coated Balloons in China (K Units)
Table 37. Key Drug-Coated Balloons Players in Japan
Table 38. Import & Export of Drug-Coated Balloons in Japan (K Units)
Table 39. Global Drug-Coated Balloons Consumption by Regions (2015-2020) (K Units)
Table 40. Global Drug-Coated Balloons Consumption Market Share by Regions (2015-2020)
Table 41. North America Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 42. North America Drug-Coated Balloons Consumption by Countries (2015-2020) (K Units)
Table 43. Europe Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 44. Europe Drug-Coated Balloons Consumption by Countries (2015-2020) (K Units)
Table 45. Asia Pacific Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 46. Asia Pacific Drug-Coated Balloons Consumption Market Share by Application (2015-2020) (K Units)
Table 47. Asia Pacific Drug-Coated Balloons Consumption by Regions (2015-2020) (K Units)
Table 48. Latin America Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 49. Latin America Drug-Coated Balloons Consumption by Countries (2015-2020) (K Units)
Table 50. Middle East and Africa Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 51. Middle East and Africa Drug-Coated Balloons Consumption by Countries (2015-2020) (K Units)
Table 52. Global Drug-Coated Balloons Production by Type (2015-2020) (K Units)
Table 53. Global Drug-Coated Balloons Production Share by Type (2015-2020)
Table 54. Global Drug-Coated Balloons Revenue by Type (2015-2020) (Million US$)
Table 55. Global Drug-Coated Balloons Revenue Share by Type (2015-2020)
Table 56. Drug-Coated Balloons Price by Type 2015-2020 (USD/Unit)
Table 57. Global Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 58. Global Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 59. Global Drug-Coated Balloons Consumption Share by Application (2015-2020)
Table 60. Medtronic Corporation Information
Table 61. Medtronic Description and Major Businesses
Table 62. Medtronic Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. Medtronic Product
Table 64. Medtronic Recent Development
Table 65. BD Corporation Information
Table 66. BD Description and Major Businesses
Table 67. BD Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. BD Product
Table 69. BD Recent Development
Table 70. B. Braun Melsungen Corporation Information
Table 71. B. Braun Melsungen Description and Major Businesses
Table 72. B. Braun Melsungen Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. B. Braun Melsungen Product
Table 74. B. Braun Melsungen Recent Development
Table 75. Koninklijke Philips Corporation Information
Table 76. Koninklijke Philips Description and Major Businesses
Table 77. Koninklijke Philips Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Koninklijke Philips Product
Table 79. Koninklijke Philips Recent Development
Table 80. Boston Scientific Corporation Information
Table 81. Boston Scientific Description and Major Businesses
Table 82. Boston Scientific Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Boston Scientific Product
Table 84. Boston Scientific Recent Development
Table 85. Opto Circuits (India) Corporation Information
Table 86. Opto Circuits (India) Description and Major Businesses
Table 87. Opto Circuits (India) Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Opto Circuits (India) Product
Table 89. Opto Circuits (India) Recent Development
Table 90. Acotec Scientific Corporation Information
Table 91. Acotec Scientific Description and Major Businesses
Table 92. Acotec Scientific Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Acotec Scientific Product
Table 94. Acotec Scientific Recent Development
Table 95. AR Baltic Medical Corporation Information
Table 96. AR Baltic Medical Description and Major Businesses
Table 97. AR Baltic Medical Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. AR Baltic Medical Product
Table 99. AR Baltic Medical Recent Development
Table 100. Acrostak Corporation Information
Table 101. Acrostak Description and Major Businesses
Table 102. Acrostak Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Acrostak Product
Table 104. Acrostak Recent Development
Table 105. Biosensors International Group Corporation Information
Table 106. Biosensors International Group Description and Major Businesses
Table 107. Biosensors International Group Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Biosensors International Group Product
Table 109. Biosensors International Group Recent Development
Table 110. BioMed Corporation Information
Table 111. BioMed Description and Major Businesses
Table 112. BioMed Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. BioMed Product
Table 114. BioMed Recent Development
Table 115. Concept Medical Corporation Information
Table 116. Concept Medical Description and Major Businesses
Table 117. Concept Medical Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Concept Medical Product
Table 119. Concept Medical Recent Development
Table 120. Cardionovum Corporation Information
Table 121. Cardionovum Description and Major Businesses
Table 122. Cardionovum Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Cardionovum Product
Table 124. Cardionovum Recent Development
Table 125. Endocor Corporation Information
Table 126. Endocor Description and Major Businesses
Table 127. Endocor Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Endocor Product
Table 129. Endocor Recent Development
Table 130. Hexacath Sverige Corporation Information
Table 131. Hexacath Sverige Description and Major Businesses
Table 132. Hexacath Sverige Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Hexacath Sverige Product
Table 134. Hexacath Sverige Recent Development
Table 135. iVascular SLU Corporation Information
Table 136. iVascular SLU Description and Major Businesses
Table 137. iVascular SLU Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. iVascular SLU Product
Table 139. iVascular SLU Recent Development
Table 140. Minvasys Corporation Information
Table 141. Minvasys Description and Major Businesses
Table 142. Minvasys Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Minvasys Product
Table 144. Minvasys Recent Development
Table 145. MedAlliance Corporation Information
Table 146. MedAlliance Description and Major Businesses
Table 147. MedAlliance Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. MedAlliance Product
Table 149. MedAlliance Recent Development
Table 150. QT Vascular Corporation Information
Table 151. QT Vascular Description and Major Businesses
Table 152. QT Vascular Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. QT Vascular Product
Table 154. QT Vascular Recent Development
Table 155. RD Global-Invamed Corporation Information
Table 156. RD Global-Invamed Description and Major Businesses
Table 157. RD Global-Invamed Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. RD Global-Invamed Product
Table 159. RD Global-Invamed Recent Development
Table 160. SurModics Corporation Information
Table 161. SurModics Description and Major Businesses
Table 162. SurModics Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. SurModics Product
Table 164. SurModics Recent Development
Table 165. Terumo Corporation Information
Table 166. Terumo Description and Major Businesses
Table 167. Terumo Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. Terumo Product
Table 169. Terumo Recent Development
Table 170. Wellinq Corporation Information
Table 171. Wellinq Description and Major Businesses
Table 172. Wellinq Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 173. Wellinq Product
Table 174. Wellinq Recent Development
Table 175. Global Drug-Coated Balloons Revenue Forecast by Region (2021-2026) (Million US$)
Table 176. Global Drug-Coated Balloons Production Forecast by Regions (2021-2026) (K Units)
Table 177. Global Drug-Coated Balloons Production Forecast by Type (2021-2026) (K Units)
Table 178. Global Drug-Coated Balloons Revenue Forecast by Type (2021-2026) (Million US$)
Table 179. North America Drug-Coated Balloons Consumption Forecast by Regions (2021-2026) (K Units)
Table 180. Europe Drug-Coated Balloons Consumption Forecast by Regions (2021-2026) (K Units)
Table 181. Asia Pacific Drug-Coated Balloons Consumption Forecast by Regions (2021-2026) (K Units)
Table 182. Latin America Drug-Coated Balloons Consumption Forecast by Regions (2021-2026) (K Units)
Table 183. Middle East and Africa Drug-Coated Balloons Consumption Forecast by Regions (2021-2026) (K Units)
Table 184. Drug-Coated Balloons Distributors List
Table 185. Drug-Coated Balloons Customers List
Table 186. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 187. Key Challenges
Table 188. Market Risks
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
Table 1. Drug-Coated Balloons Key Market Segments in This Study
Table 2. Ranking of Global Top Drug-Coated Balloons Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Drug-Coated Balloons Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of DCB for Peripheral Artery Disease
Table 5. Major Manufacturers of DCB for Coronary Artery Disease
Table 6. Major Manufacturers of DCB for Other Indications
Table 7. COVID-19 Impact Global Market: (Four Drug-Coated Balloons Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Drug-Coated Balloons Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Drug-Coated Balloons Players to Combat Covid-19 Impact
Table 12. Global Drug-Coated Balloons Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Drug-Coated Balloons Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Drug-Coated Balloons by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug-Coated Balloons as of 2019)
Table 16. Drug-Coated Balloons Manufacturing Base Distribution and Headquarters
Table 17. Manufacturers Drug-Coated Balloons Product Offered
Table 18. Date of Manufacturers Enter into Drug-Coated Balloons Market
Table 19. Key Trends for Drug-Coated Balloons Markets & Products
Table 20. Main Points Interviewed from Key Drug-Coated Balloons Players
Table 21. Global Drug-Coated Balloons Production Capacity by Manufacturers (2015-2020) (K Units)
Table 22. Global Drug-Coated Balloons Production Share by Manufacturers (2015-2020)
Table 23. Drug-Coated Balloons Revenue by Manufacturers (2015-2020) (Million US$)
Table 24. Drug-Coated Balloons Revenue Share by Manufacturers (2015-2020)
Table 25. Drug-Coated Balloons Price by Manufacturers 2015-2020 (USD/Unit)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Drug-Coated Balloons Production by Regions (2015-2020) (K Units)
Table 28. Global Drug-Coated Balloons Production Market Share by Regions (2015-2020)
Table 29. Global Drug-Coated Balloons Revenue by Regions (2015-2020) (US$ Million)
Table 30. Global Drug-Coated Balloons Revenue Market Share by Regions (2015-2020)
Table 31. Key Drug-Coated Balloons Players in North America
Table 32. Import & Export of Drug-Coated Balloons in North America (K Units)
Table 33. Key Drug-Coated Balloons Players in Europe
Table 34. Import & Export of Drug-Coated Balloons in Europe (K Units)
Table 35. Key Drug-Coated Balloons Players in China
Table 36. Import & Export of Drug-Coated Balloons in China (K Units)
Table 37. Key Drug-Coated Balloons Players in Japan
Table 38. Import & Export of Drug-Coated Balloons in Japan (K Units)
Table 39. Global Drug-Coated Balloons Consumption by Regions (2015-2020) (K Units)
Table 40. Global Drug-Coated Balloons Consumption Market Share by Regions (2015-2020)
Table 41. North America Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 42. North America Drug-Coated Balloons Consumption by Countries (2015-2020) (K Units)
Table 43. Europe Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 44. Europe Drug-Coated Balloons Consumption by Countries (2015-2020) (K Units)
Table 45. Asia Pacific Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 46. Asia Pacific Drug-Coated Balloons Consumption Market Share by Application (2015-2020) (K Units)
Table 47. Asia Pacific Drug-Coated Balloons Consumption by Regions (2015-2020) (K Units)
Table 48. Latin America Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 49. Latin America Drug-Coated Balloons Consumption by Countries (2015-2020) (K Units)
Table 50. Middle East and Africa Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 51. Middle East and Africa Drug-Coated Balloons Consumption by Countries (2015-2020) (K Units)
Table 52. Global Drug-Coated Balloons Production by Type (2015-2020) (K Units)
Table 53. Global Drug-Coated Balloons Production Share by Type (2015-2020)
Table 54. Global Drug-Coated Balloons Revenue by Type (2015-2020) (Million US$)
Table 55. Global Drug-Coated Balloons Revenue Share by Type (2015-2020)
Table 56. Drug-Coated Balloons Price by Type 2015-2020 (USD/Unit)
Table 57. Global Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 58. Global Drug-Coated Balloons Consumption by Application (2015-2020) (K Units)
Table 59. Global Drug-Coated Balloons Consumption Share by Application (2015-2020)
Table 60. Medtronic Corporation Information
Table 61. Medtronic Description and Major Businesses
Table 62. Medtronic Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. Medtronic Product
Table 64. Medtronic Recent Development
Table 65. BD Corporation Information
Table 66. BD Description and Major Businesses
Table 67. BD Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. BD Product
Table 69. BD Recent Development
Table 70. B. Braun Melsungen Corporation Information
Table 71. B. Braun Melsungen Description and Major Businesses
Table 72. B. Braun Melsungen Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. B. Braun Melsungen Product
Table 74. B. Braun Melsungen Recent Development
Table 75. Koninklijke Philips Corporation Information
Table 76. Koninklijke Philips Description and Major Businesses
Table 77. Koninklijke Philips Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Koninklijke Philips Product
Table 79. Koninklijke Philips Recent Development
Table 80. Boston Scientific Corporation Information
Table 81. Boston Scientific Description and Major Businesses
Table 82. Boston Scientific Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Boston Scientific Product
Table 84. Boston Scientific Recent Development
Table 85. Opto Circuits (India) Corporation Information
Table 86. Opto Circuits (India) Description and Major Businesses
Table 87. Opto Circuits (India) Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Opto Circuits (India) Product
Table 89. Opto Circuits (India) Recent Development
Table 90. Acotec Scientific Corporation Information
Table 91. Acotec Scientific Description and Major Businesses
Table 92. Acotec Scientific Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Acotec Scientific Product
Table 94. Acotec Scientific Recent Development
Table 95. AR Baltic Medical Corporation Information
Table 96. AR Baltic Medical Description and Major Businesses
Table 97. AR Baltic Medical Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. AR Baltic Medical Product
Table 99. AR Baltic Medical Recent Development
Table 100. Acrostak Corporation Information
Table 101. Acrostak Description and Major Businesses
Table 102. Acrostak Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Acrostak Product
Table 104. Acrostak Recent Development
Table 105. Biosensors International Group Corporation Information
Table 106. Biosensors International Group Description and Major Businesses
Table 107. Biosensors International Group Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Biosensors International Group Product
Table 109. Biosensors International Group Recent Development
Table 110. BioMed Corporation Information
Table 111. BioMed Description and Major Businesses
Table 112. BioMed Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. BioMed Product
Table 114. BioMed Recent Development
Table 115. Concept Medical Corporation Information
Table 116. Concept Medical Description and Major Businesses
Table 117. Concept Medical Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Concept Medical Product
Table 119. Concept Medical Recent Development
Table 120. Cardionovum Corporation Information
Table 121. Cardionovum Description and Major Businesses
Table 122. Cardionovum Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Cardionovum Product
Table 124. Cardionovum Recent Development
Table 125. Endocor Corporation Information
Table 126. Endocor Description and Major Businesses
Table 127. Endocor Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Endocor Product
Table 129. Endocor Recent Development
Table 130. Hexacath Sverige Corporation Information
Table 131. Hexacath Sverige Description and Major Businesses
Table 132. Hexacath Sverige Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Hexacath Sverige Product
Table 134. Hexacath Sverige Recent Development
Table 135. iVascular SLU Corporation Information
Table 136. iVascular SLU Description and Major Businesses
Table 137. iVascular SLU Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. iVascular SLU Product
Table 139. iVascular SLU Recent Development
Table 140. Minvasys Corporation Information
Table 141. Minvasys Description and Major Businesses
Table 142. Minvasys Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Minvasys Product
Table 144. Minvasys Recent Development
Table 145. MedAlliance Corporation Information
Table 146. MedAlliance Description and Major Businesses
Table 147. MedAlliance Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. MedAlliance Product
Table 149. MedAlliance Recent Development
Table 150. QT Vascular Corporation Information
Table 151. QT Vascular Description and Major Businesses
Table 152. QT Vascular Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. QT Vascular Product
Table 154. QT Vascular Recent Development
Table 155. RD Global-Invamed Corporation Information
Table 156. RD Global-Invamed Description and Major Businesses
Table 157. RD Global-Invamed Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. RD Global-Invamed Product
Table 159. RD Global-Invamed Recent Development
Table 160. SurModics Corporation Information
Table 161. SurModics Description and Major Businesses
Table 162. SurModics Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. SurModics Product
Table 164. SurModics Recent Development
Table 165. Terumo Corporation Information
Table 166. Terumo Description and Major Businesses
Table 167. Terumo Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. Terumo Product
Table 169. Terumo Recent Development
Table 170. Wellinq Corporation Information
Table 171. Wellinq Description and Major Businesses
Table 172. Wellinq Drug-Coated Balloons Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 173. Wellinq Product
Table 174. Wellinq Recent Development
Table 175. Global Drug-Coated Balloons Revenue Forecast by Region (2021-2026) (Million US$)
Table 176. Global Drug-Coated Balloons Production Forecast by Regions (2021-2026) (K Units)
Table 177. Global Drug-Coated Balloons Production Forecast by Type (2021-2026) (K Units)
Table 178. Global Drug-Coated Balloons Revenue Forecast by Type (2021-2026) (Million US$)
Table 179. North America Drug-Coated Balloons Consumption Forecast by Regions (2021-2026) (K Units)
Table 180. Europe Drug-Coated Balloons Consumption Forecast by Regions (2021-2026) (K Units)
Table 181. Asia Pacific Drug-Coated Balloons Consumption Forecast by Regions (2021-2026) (K Units)
Table 182. Latin America Drug-Coated Balloons Consumption Forecast by Regions (2021-2026) (K Units)
Table 183. Middle East and Africa Drug-Coated Balloons Consumption Forecast by Regions (2021-2026) (K Units)
Table 184. Drug-Coated Balloons Distributors List
Table 185. Drug-Coated Balloons Customers List
Table 186. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 187. Key Challenges
Table 188. Market Risks
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Drug-Coated Balloons Product Picture
Figure 2. Global Drug-Coated Balloons Production Market Share by Type in 2020 & 2026
Figure 3. DCB for Peripheral Artery Disease Product Picture
Figure 4. DCB for Coronary Artery Disease Product Picture
Figure 5. DCB for Other Indications Product Picture
Figure 6. Global Drug-Coated Balloons Consumption Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Cardiac Catheterization Labs
Figure 9. ASCs
Figure 10. Drug-Coated Balloons Report Years Considered
Figure 11. Global Drug-Coated Balloons Revenue 2015-2026 (Million US$)
Figure 12. Global Drug-Coated Balloons Production Capacity 2015-2026 (K Units)
Figure 13. Global Drug-Coated Balloons Production 2015-2026 (K Units)
Figure 14. Global Drug-Coated Balloons Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 15. Drug-Coated Balloons Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Drug-Coated Balloons Production Share by Manufacturers in 2015
Figure 17. The Top 10 and Top 5 Players Market Share by Drug-Coated Balloons Revenue in 2019
Figure 18. Global Drug-Coated Balloons Production Market Share by Region (2015-2020)
Figure 19. Drug-Coated Balloons Production Growth Rate in North America (2015-2020) (K Units)
Figure 20. Drug-Coated Balloons Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 21. Drug-Coated Balloons Production Growth Rate in Europe (2015-2020) (K Units)
Figure 22. Drug-Coated Balloons Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 23. Drug-Coated Balloons Production Growth Rate in China (2015-2020) (K Units)
Figure 24. Drug-Coated Balloons Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 25. Drug-Coated Balloons Production Growth Rate in Japan (2015-2020) (K Units)
Figure 26. Drug-Coated Balloons Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 27. Global Drug-Coated Balloons Consumption Market Share by Regions 2015-2020
Figure 28. North America Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 29. North America Drug-Coated Balloons Consumption Market Share by Application in 2019
Figure 30. North America Drug-Coated Balloons Consumption Market Share by Countries in 2019
Figure 31. U.S. Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Canada Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Europe Drug-Coated Balloons Consumption Market Share by Application in 2019
Figure 35. Europe Drug-Coated Balloons Consumption Market Share by Countries in 2019
Figure 36. Germany Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. France Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. U.K. Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Italy Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Russia Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Asia Pacific Drug-Coated Balloons Consumption and Growth Rate (K Units)
Figure 42. Asia Pacific Drug-Coated Balloons Consumption Market Share by Application in 2019
Figure 43. Asia Pacific Drug-Coated Balloons Consumption Market Share by Regions in 2019
Figure 44. China Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. Japan Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. India Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Australia Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Taiwan Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Indonesia Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Thailand Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Malaysia Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Philippines Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Vietnam Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Latin America Drug-Coated Balloons Consumption and Growth Rate (K Units)
Figure 56. Latin America Drug-Coated Balloons Consumption Market Share by Application in 2019
Figure 57. Latin America Drug-Coated Balloons Consumption Market Share by Countries in 2019
Figure 58. Mexico Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Brazil Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Argentina Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Middle East and Africa Drug-Coated Balloons Consumption and Growth Rate (K Units)
Figure 62. Middle East and Africa Drug-Coated Balloons Consumption Market Share by Application in 2019
Figure 63. Middle East and Africa Drug-Coated Balloons Consumption Market Share by Countries in 2019
Figure 64. Turkey Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Saudi Arabia Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. U.A.E Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Global Drug-Coated Balloons Production Market Share by Type (2015-2020)
Figure 68. Global Drug-Coated Balloons Production Market Share by Type in 2019
Figure 69. Global Drug-Coated Balloons Revenue Market Share by Type (2015-2020)
Figure 70. Global Drug-Coated Balloons Revenue Market Share by Type in 2019
Figure 71. Global Drug-Coated Balloons Production Market Share Forecast by Type (2021-2026)
Figure 72. Global Drug-Coated Balloons Revenue Market Share Forecast by Type (2021-2026)
Figure 73. Global Drug-Coated Balloons Market Share by Price Range (2015-2020)
Figure 74. Global Drug-Coated Balloons Consumption Market Share by Application (2015-2020)
Figure 75. Global Drug-Coated Balloons Value (Consumption) Market Share by Application (2015-2020)
Figure 76. Global Drug-Coated Balloons Consumption Market Share Forecast by Application (2021-2026)
Figure 77. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. B. Braun Melsungen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Koninklijke Philips Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Opto Circuits (India) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Acotec Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. AR Baltic Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Acrostak Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Biosensors International Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. BioMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Concept Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Cardionovum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Endocor Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Hexacath Sverige Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. iVascular SLU Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Minvasys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. MedAlliance Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. QT Vascular Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. RD Global-Invamed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. SurModics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Terumo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Wellinq Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Global Drug-Coated Balloons Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 101. Global Drug-Coated Balloons Revenue Market Share Forecast by Regions ((2021-2026))
Figure 102. Global Drug-Coated Balloons Production Forecast by Regions (2021-2026) (K Units)
Figure 103. North America Drug-Coated Balloons Production Forecast (2021-2026) (K Units)
Figure 104. North America Drug-Coated Balloons Revenue Forecast (2021-2026) (US$ Million)
Figure 105. Europe Drug-Coated Balloons Production Forecast (2021-2026) (K Units)
Figure 106. Europe Drug-Coated Balloons Revenue Forecast (2021-2026) (US$ Million)
Figure 107. China Drug-Coated Balloons Production Forecast (2021-2026) (K Units)
Figure 108. China Drug-Coated Balloons Revenue Forecast (2021-2026) (US$ Million)
Figure 109. Japan Drug-Coated Balloons Production Forecast (2021-2026) (K Units)
Figure 110. Japan Drug-Coated Balloons Revenue Forecast (2021-2026) (US$ Million)
Figure 111. Global Drug-Coated Balloons Consumption Market Share Forecast by Region (2021-2026)
Figure 112. Drug-Coated Balloons Value Chain
Figure 113. Channels of Distribution
Figure 114. Distributors Profiles
Figure 115. Porter's Five Forces Analysis
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
Figure 1. Drug-Coated Balloons Product Picture
Figure 2. Global Drug-Coated Balloons Production Market Share by Type in 2020 & 2026
Figure 3. DCB for Peripheral Artery Disease Product Picture
Figure 4. DCB for Coronary Artery Disease Product Picture
Figure 5. DCB for Other Indications Product Picture
Figure 6. Global Drug-Coated Balloons Consumption Market Share by Application in 2020 & 2026
Figure 7. Hospitals
Figure 8. Cardiac Catheterization Labs
Figure 9. ASCs
Figure 10. Drug-Coated Balloons Report Years Considered
Figure 11. Global Drug-Coated Balloons Revenue 2015-2026 (Million US$)
Figure 12. Global Drug-Coated Balloons Production Capacity 2015-2026 (K Units)
Figure 13. Global Drug-Coated Balloons Production 2015-2026 (K Units)
Figure 14. Global Drug-Coated Balloons Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 15. Drug-Coated Balloons Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Drug-Coated Balloons Production Share by Manufacturers in 2015
Figure 17. The Top 10 and Top 5 Players Market Share by Drug-Coated Balloons Revenue in 2019
Figure 18. Global Drug-Coated Balloons Production Market Share by Region (2015-2020)
Figure 19. Drug-Coated Balloons Production Growth Rate in North America (2015-2020) (K Units)
Figure 20. Drug-Coated Balloons Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 21. Drug-Coated Balloons Production Growth Rate in Europe (2015-2020) (K Units)
Figure 22. Drug-Coated Balloons Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 23. Drug-Coated Balloons Production Growth Rate in China (2015-2020) (K Units)
Figure 24. Drug-Coated Balloons Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 25. Drug-Coated Balloons Production Growth Rate in Japan (2015-2020) (K Units)
Figure 26. Drug-Coated Balloons Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 27. Global Drug-Coated Balloons Consumption Market Share by Regions 2015-2020
Figure 28. North America Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 29. North America Drug-Coated Balloons Consumption Market Share by Application in 2019
Figure 30. North America Drug-Coated Balloons Consumption Market Share by Countries in 2019
Figure 31. U.S. Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Canada Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Europe Drug-Coated Balloons Consumption Market Share by Application in 2019
Figure 35. Europe Drug-Coated Balloons Consumption Market Share by Countries in 2019
Figure 36. Germany Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. France Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. U.K. Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Italy Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Russia Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Asia Pacific Drug-Coated Balloons Consumption and Growth Rate (K Units)
Figure 42. Asia Pacific Drug-Coated Balloons Consumption Market Share by Application in 2019
Figure 43. Asia Pacific Drug-Coated Balloons Consumption Market Share by Regions in 2019
Figure 44. China Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. Japan Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. India Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Australia Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Taiwan Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Indonesia Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Thailand Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Malaysia Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Philippines Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Vietnam Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Latin America Drug-Coated Balloons Consumption and Growth Rate (K Units)
Figure 56. Latin America Drug-Coated Balloons Consumption Market Share by Application in 2019
Figure 57. Latin America Drug-Coated Balloons Consumption Market Share by Countries in 2019
Figure 58. Mexico Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Brazil Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Argentina Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Middle East and Africa Drug-Coated Balloons Consumption and Growth Rate (K Units)
Figure 62. Middle East and Africa Drug-Coated Balloons Consumption Market Share by Application in 2019
Figure 63. Middle East and Africa Drug-Coated Balloons Consumption Market Share by Countries in 2019
Figure 64. Turkey Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Saudi Arabia Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. U.A.E Drug-Coated Balloons Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Global Drug-Coated Balloons Production Market Share by Type (2015-2020)
Figure 68. Global Drug-Coated Balloons Production Market Share by Type in 2019
Figure 69. Global Drug-Coated Balloons Revenue Market Share by Type (2015-2020)
Figure 70. Global Drug-Coated Balloons Revenue Market Share by Type in 2019
Figure 71. Global Drug-Coated Balloons Production Market Share Forecast by Type (2021-2026)
Figure 72. Global Drug-Coated Balloons Revenue Market Share Forecast by Type (2021-2026)
Figure 73. Global Drug-Coated Balloons Market Share by Price Range (2015-2020)
Figure 74. Global Drug-Coated Balloons Consumption Market Share by Application (2015-2020)
Figure 75. Global Drug-Coated Balloons Value (Consumption) Market Share by Application (2015-2020)
Figure 76. Global Drug-Coated Balloons Consumption Market Share Forecast by Application (2021-2026)
Figure 77. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. B. Braun Melsungen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Koninklijke Philips Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Opto Circuits (India) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Acotec Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. AR Baltic Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Acrostak Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Biosensors International Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. BioMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Concept Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Cardionovum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Endocor Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Hexacath Sverige Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. iVascular SLU Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Minvasys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. MedAlliance Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. QT Vascular Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. RD Global-Invamed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. SurModics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Terumo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Wellinq Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Global Drug-Coated Balloons Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 101. Global Drug-Coated Balloons Revenue Market Share Forecast by Regions ((2021-2026))
Figure 102. Global Drug-Coated Balloons Production Forecast by Regions (2021-2026) (K Units)
Figure 103. North America Drug-Coated Balloons Production Forecast (2021-2026) (K Units)
Figure 104. North America Drug-Coated Balloons Revenue Forecast (2021-2026) (US$ Million)
Figure 105. Europe Drug-Coated Balloons Production Forecast (2021-2026) (K Units)
Figure 106. Europe Drug-Coated Balloons Revenue Forecast (2021-2026) (US$ Million)
Figure 107. China Drug-Coated Balloons Production Forecast (2021-2026) (K Units)
Figure 108. China Drug-Coated Balloons Revenue Forecast (2021-2026) (US$ Million)
Figure 109. Japan Drug-Coated Balloons Production Forecast (2021-2026) (K Units)
Figure 110. Japan Drug-Coated Balloons Revenue Forecast (2021-2026) (US$ Million)
Figure 111. Global Drug-Coated Balloons Consumption Market Share Forecast by Region (2021-2026)
Figure 112. Drug-Coated Balloons Value Chain
Figure 113. Channels of Distribution
Figure 114. Distributors Profiles
Figure 115. Porter's Five Forces Analysis
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
